Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |